Literature DB >> 485201

Pulmonary candidiasis in cystic fibrosis.

B M Jenner, L I Landau, P D Phelan.   

Abstract

A child with cystic fibrosis and asthma developed pulmonary candidiasis. Predisposing factors in this patient were prolonged antibiotic therapy, high-dose corticosteroids, and intravenous catherisation. A diagnosis was made by lung puncture and confirmed by rapid response to 5-fluorocytosine.

Entities:  

Mesh：

Year:  1979        PMID： 485201      PMCID： PMC1545491          DOI： 10.1136/adc.54.7.555

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  7 in total

1.  Synergism of amphotericin B and 5-fluorocytosine for candida species.

Authors:  J Z Montgomerie; J E Edwards; L B Guze
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

2.  Pulmonary candidiasis treated with 5-fluorocytosine.

Authors:  A Kohlschütter; B Pelet
Journal:  Arch Dis Child       Date:  1974-02       Impact factor: 3.791

3.  Fungal infection in acute leukemia.

Authors:  H S Mirsky; J Cuttner
Journal:  Cancer       Date:  1972-08       Impact factor: 6.860

4.  Needle diagnosis of pneumonitis. Value in high-risk patients.

Authors:  P D Bandt; N Blank; R A Castellino
Journal:  JAMA       Date:  1972-06-19       Impact factor: 56.272

5.  Problems in the diagnosis and treatment of systemic candidiasis.

Authors:  E Goldstein; P D Hoeprich
Journal:  J Infect Dis       Date:  1972-02       Impact factor: 5.226

6.  Diagnostic lung puncture in the pneumonias of infants and children.

Authors:  J O Klein
Journal:  Pediatrics       Date:  1969-10       Impact factor: 7.124

7.  Experimental disseminated candidiasis. II. Administration of glucocorticosteroids, susceptibility to infection, and immunity.

Authors:  D L Hurley; J E Balow; A S Fauci
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226
  7 in total
  4 in total

1.  Serologic response to Candida albicans and Aspergillus fumigatus in cystic fibrosis.

Authors:  B Przyklenk; A Bauernfeind; G Hörl; G Emminger
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

2.  Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains.

Authors:  Giovanni Di Bonaventura; Veronica Lupetti; Simone De Fabritiis; Alessandra Piccirilli; Annamaria Porreca; Marta Di Nicola; Arianna Pompilio
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

3.  Exophiala dermatitidis pneumonia in cystic fibrosis.

Authors:  G Kusenbach; H Skopnik; G Haase; F Friedrichs; H Döhmen
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

4.  Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity.

Authors:  Francesco Imperi; Francesco Massai; Marcella Facchini; Emanuela Frangipani; Daniela Visaggio; Livia Leoni; Alessandra Bragonzi; Paolo Visca
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.